NICHOLAS ATHAS: Open Payments
NPI 1891945887 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 15 payments from 10 companies in 2025. Trend: 2023 $222 · 2024 $471 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 3 | $77 |
| Ethicon US, LLC | 2 | $63 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| Janssen Biotech, Inc. | 2 | $40 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Caris MPI, Inc. | 1 | $23 |
| AngioDynamics, Inc. | 1 | $23 |
| PharmaEssentia USA Corporation | 1 | $21 |
Products named: Lenvima, LONSURF, Enseal X1, KEYTRUDA, Echelon Flex, Vitrakvi, LIBTAYO, LYNPARZA.
Industry payments across MD — which companies pay providers there.
